. Flow-chart outlining the search strategy. SRIs, serotonin reuptake inhibitors; CA, congenital anomalies; CHA, congenital heart anomalies. Table S1 . Studies (2005 Studies ( -2015 that found an association between SRI use in early pregnancy and the risk of congenital anomalies including CHA. Abbreviations: SRI, serotonin reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; CHA, congenital heart anomalies; ASD, atrial septal defect; VSD, ventricular septal defect; TOP, termination of pregnancy; LMP, last menstrual period; PDA, patent ductus arteriosus; NBDPS, the National Birth Defects Prevention Study; LVOTO, left ventricular outflow tract obstruction; U/S, ultrasound; TIS, Teratology Information Service. Table S2 . Studies (2005 Studies ( -2015 reporting no association between SRI use in early pregnancy and the risk of congenital anomalies including CHA. SRI: serotonin reuptake inhibitor; SSRI: selective serotonin reuptake inhibitor; CHA: congenital heart anomalies; LMP: last menstrual period; VSD: ventricular septal defect; TCA: tricyclic antidepressants; TOP: termination of pregnancy; SNRI: serotonin/noradrenaline reuptake inhibitor; NRI: noradrenaline reuptake inhibitor.
